4.4 Article

Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans

Related references

Note: Only part of the references are listed.
Article Neurosciences

The NK1 Receptor Antagonist L822429 Reduces Heroin Reinforcement

Estelle Barbier et al.

NEUROPSYCHOPHARMACOLOGY (2013)

Article Psychology, Clinical

Opioid-Like Effects of the Neurokinin 1 Antagonist Aprepitant in Patients Maintained on and Briefly Withdrawn from Methadone

Jermaine D. Jones et al.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2013)

Article Radiology, Nuclear Medicine & Medical Imaging

A pharmacokinetic PET study of NK1 receptor occupancy

Stefano Zamuner et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Clinical Neurology

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

Johannes Tauscher et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)

Article Biochemistry & Molecular Biology

Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429

Nicolas Singewald et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Multidisciplinary Sciences

Neurokinin 1 receptor antagonism as a possible therapy for alcoholism

David T. George et al.

SCIENCE (2008)

Article Pharmacology & Pharmacy

Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitant

RI Sanchez et al.

DRUG METABOLISM AND DISPOSITION (2004)

Article Pharmacology & Pharmacy

Effects of aprepitant on cytochrome P450 3A4 activity using midazolam as a probe

AK Majumdar et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)